{"id":939,"date":"2026-05-25T03:50:07","date_gmt":"2026-05-25T03:50:07","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=939"},"modified":"2026-06-15T11:27:49","modified_gmt":"2026-06-15T11:27:49","slug":"pentapeptide-18-200mg","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/pentapeptide-18-200mg\/","title":{"rendered":"Pentapeptide-18 (200mg)"},"content":{"rendered":"

Pentapeptide-18 (200mg) Research Peptide: A Unique Neuropeptide for Dermal Research<\/span><\/h1>\n

If your research targets the complex biology of neuromuscular communication, dermal ageing, or the development of next\u2011generation topical formulation science,\u00a0<\/span>Pentapeptide-18 (200mg) research peptide<\/span><\/strong>\u00a0offers a uniquely refined experimental tool. Also known by its INCI name Pentapeptide-18 and the trademarked designation Leuphasyl\u00ae, this synthetic pentapeptide was specifically designed to interact with neuronal communication pathways in the skin<\/span>. <\/span><\/p>\n

By mimicking the natural sequence of the endogenous neuropeptide Leu\u2011enkephalin, Pentapeptide-18 acts as a targeted neuromodulator, binding to enkephalin receptors on neuronal cell membranes to reduce acetylcholine (ACh) release<\/span>. This decreases the intensity of repeated facial muscle micro\u2011contractions that drive the formation of dynamic expression lines, without the tissue damage or spreading concerns associated with other interventions.<\/span><\/p>\n

At\u00a0<\/span>Wuhan Top Miracle Peptides<\/span><\/strong>, we supply high\u2011purity\u00a0<\/span>Pentapeptide-18 (200mg) research peptide<\/span><\/strong>\u00a0to research institutions and wholesale buyers across the\u00a0<\/span>United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA<\/span><\/strong>. Every batch is lyophilised, HPLC\u2011verified to >99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your studies into dermal neuromuscular signalling, neurocosmetic formulation science, and expression line biology begin with uncompromising quality.<\/span><\/p>\n

What Is Pentapeptide-18 and How Does It Work?<\/span><\/h2>\n

To fully appreciate the research potential of\u00a0<\/span>Pentapeptide-18 (200mg) research peptide<\/span><\/strong>, it is essential to understand its unique biochemical design and the precise mechanistic hypotheses that drive current scientific inquiry.<\/span><\/p>\n

The Tyr-D-Ala-Gly-Phe-Leu Pentapeptide<\/span><\/h3>\n

Pentapeptide-18 is a synthetic peptide composed of five amino acids: tyrosine, D\u2011alanine, glycine, phenylalanine, and leucine. Its one\u2011letter code sequence is\u00a0<\/span>YAGFL<\/span><\/strong>, with the three\u2011letter representation\u00a0<\/span>H\u2011Tyr\u2011D\u2011Ala\u2011Gly\u2011Phe\u2011Leu\u2011OH<\/span><\/strong>. Its molecular formula is\u00a0<\/span>C\u2082\u2089H\u2083\u2089N\u2085O\u2087<\/span><\/strong>, and its molecular weight is approximately\u00a0<\/span>569.6\u2013569.65\u202fg\/mol<\/span><\/strong>. Its CAS number is\u00a0<\/span>64963\u201101\u20115<\/span><\/strong>.<\/span><\/p>\n

The presence of a\u00a0<\/span>D\u2011alanine residue<\/span><\/strong>\u00a0at the second position is a critical structural feature. This substitution of the naturally occurring L\u2011alanine with its stereoisomer confers significantly enhanced resistance to proteolytic degradation compared to native enkephalin peptides, making Pentapeptide-18 more stable in research and formulation contexts<\/span>.<\/span><\/p>\n

Proposed Mechanism of Action: Enkephalin\u2011Receptor Mediated Neuromodulation<\/span><\/h3>\n

The biological activity of\u00a0<\/span>Pentapeptide-18 (200mg) research peptide<\/span><\/strong>\u00a0is rooted in its interaction with the endogenous enkephalin system and subsequent modulation of neurotransmitter release. This mechanism is distinct from other topical neuropeptides and offers a complementary pathway for research.<\/span><\/p>\n

Enkephalin\u2011Receptor Binding:<\/span><\/strong>\u00a0Pentapeptide-18 is a structural analogue of the endogenous neuropeptide Leu\u2011enkephalin. It binds directly to enkephalin receptors (\u03b4\u2011opioid and \u03bc\u2011opioid receptors) on the surface of neuronal cell membranes<\/span>.<\/span><\/p>\n

Downregulation of Acetylcholine Release:<\/span><\/strong>\u00a0This receptor binding leads to the release of inhibitory G\u2011protein subunits (G\u03b1, G\u03b2, G\u03b3), which in turn close calcium ion channels. This prevents the fusion of synaptic vesicles and reduces the release of the neurotransmitter acetylcholine (ACh) into the neuromuscular junction<\/span>.<\/span><\/p>\n

Reduction of Muscle Micro\u2011Contractions:<\/span><\/strong>\u00a0With less ACh available to trigger muscle contraction, the intensity of repeated facial muscle micro\u2011contractions\u2014the underlying cause of dynamic expression lines\u2014is diminished. This effect is reversible and does not produce the “frozen” appearance associated with botulinum toxin.<\/span><\/p>\n

Distinct Mechanism from Other Research Neuropeptides<\/span><\/h3>\n
\n
\n
<\/div>\n
<\/div>\n<\/div>\n\n\n\n\n\n\n\n
Peptide<\/span><\/strong><\/th>\nMechanism of Action<\/span><\/strong><\/th>\nResearch Niche<\/span><\/strong><\/th>\n<\/tr>\n<\/thead>\n
Pentapeptide\u201118 (Leuphasyl\u00ae)<\/span><\/strong><\/td>\nBinds enkephalin (opioid) receptors; reduces ACh release without interacting with SNARE complex<\/span><\/td>\nEnkephalin\u2011receptor pathway, alternative\/complementary pathway studies<\/span><\/td>\n<\/tr>\n
Acetyl Hexapeptide\u20118 (Argireline\u00ae)<\/span><\/td>\nInhibits SNARE complex assembly (synthaxin, SNAP\u201125) to block vesicle fusion<\/span><\/td>\nSNARE complex mechanics, neurotransmitter pathway research<\/span><\/td>\n<\/tr>\n
Dipeptide Diaminobutyroyl Benzylamide Diacetate (SYN\u2011AKE\u00ae)<\/span><\/td>\nAntagonises nicotinic acetylcholine receptors (nAChRs) to limit muscle contraction<\/span><\/td>\nNicotinic receptor signalling, alternative neuromuscular pathway research<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Key Research Applications for Pentapeptide-18 (200mg)<\/span><\/h2>\n

Pentapeptide-18 (200mg) research peptide<\/span><\/strong>\u00a0is a versatile tool with a broad range of potential applications across several domains of modern biomedical and formulation science.<\/span><\/p>\n

1. Dermal Neuromuscular Signalling & Expression Line Research<\/span><\/h3>\n

The most established and well\u2011documented research domain for Pentapeptide-18 lies in its ability to modulate neuromuscular communication in dermal tissues. Its distinct mechanism, binding to enkephalin receptors rather than directly affecting the SNARE complex or nAChRs, positions it as a powerful tool for both targeted expression line research and as a complementary agent to other neuropeptides.<\/span><\/p>\n